Mary Chapman,  features writer—

Mary graduated from Wayne State University with a degree in journalism. She began her career at United Press International, then spent a decade reporting for the Bureau of National Affairs, Inc. (now Bloomberg Industry Group). Mary has written extensively for The New York Times, and her work has appeared in publications such as Time, Newsweek, Fortune, and the Chicago Tribune. She’s won a Society of Professional Journalists award for outstanding reporting.

Articles by Mary Chapman

World Alzheimer’s Month throws spotlight on disease risk factors

As part of this month’s observance of World Alzheimer’s Month, supporters intend to raise awareness about Alzheimer’s disease and other types of dementia by pointing out the risk factors associated with the disorders. The Alzheimer’s Disease International (ADI) organizes the event, working with and supporting patient groups in…

Events, Buildings in Teal Marking Alzheimer’s Awareness Month

From sporting teal to getting a virtual memory screening, supporters across the U.S. are marking National Alzheimer’s Awareness Month, observed each November, to call attention to the progressive neurodegenerative disorder and the 6.2 million people it’s thought to affect. The Alzheimer’s Foundation of America (AFA) is offering a…

Grant Will Fund MedPharm Study of Cannabinoids’ Effects in Alzheimer’s

Cannabis researcher MedPharm has been granted funding to study the effect of phytocannabinoids — naturally occurring chemicals, called cannabinoids, from marijuana plants — on Alzheimer’s disease, with the ultimate aim of treatment development. The new funding comes from the Colorado State University Institute of Cannabis Research (ICR). It was…